title: First case of lacosamide-induced psychosis.
abstract: Lacosamide (LCM) is a newer antiepileptic drug with a favorable safety profile used in partial epilepsy as adjunctive therapy. The most common side effects include dizziness, headache, confusion, diplopia, nausea, nasopharyngitis, and vomiting. Although sporadic cases of drug-induced psychosis have been reported for some antiepileptic drugs, this was not the case for LCM. We describe the first case of LCM-induced psychosis in a patient with drug-resistant partial epilepsy during the first week of treatment initiation, stressing the importance of clinicians remaining alert for abnormal behavioral symptoms.
authors: Department of Neurology, Medical School, University Hospital of Ioannina, Ioannina, Greece. dimihat@otenet.gr
authors: Dimitrios
authors: D
authors: Chatzistefanidis
authors: Eleni
authors: E
authors: Karvouni
authors: Athanassios P
authors: AP
authors: Kyritsis
authors: Sofia
authors: S
authors: Markoula
mesh_terms: D000081:Acetamides / Q000009:adverse effects*; D000328:Adult; D000927:Anticonvulsants / Q000009:adverse effects*; D001569:Benzodiazepines / Q000627:therapeutic use; D004827:Epilepsy / Q000175:diagnosis / Q000188:drug therapy; D006801:Humans; D000078334:Lacosamide; D008297:Male; D000077152:Olanzapine; D011605:Psychoses, Substance-Induced / Q000175:diagnosis* / Q000188:drug therapy
chemical_list: D000081:Acetamides; D000927:Anticonvulsants; D001569:Benzodiazepines; D000078334:Lacosamide; D000077152:Olanzapine